Skip to main content
[Preprint]. 2022 Jun 16:2022.06.16.496428. [Version 1] doi: 10.1101/2022.06.16.496428

Figure 3. SARS-CoV-2 spike variants remain sensitive to nafamostat.

Figure 3.

Relative activity of factor Xa (125nM) with or without 10μM nafamostat in reaction with S1/S2 FRET peptide substrate (50 μM) corresponding to (A) WT ancestral sequence P681, (B) P681H substitution, and (C) P681R substitution. * P<0.05, two-tailed t-test. Error bars represent +/− SEM.